Webinar: From CE Mark to First Sale?

Market access and commercial launch both start at study design, not after approval.

MedTech companies that wait pay for it twice: once in a study that cannot carry a price argument, and again in a launch that nobody was warmed up for. Dr. Stefan Walzer (MArS Market Access & Pricing Strategy) and Thibault Vandenhove (Ooho) walk the full MedTech go-to-market timeline live, moderated by Lutz Vollmer (MArS).

 A moderated discussion via MS Teams with live Q&A.